BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26218533)

  • 1. Is Non-Contrast CT Adequate for the Evaluation of Hepatic Metastasis in Patients Who Cannot Receive Iodinated Contrast Media?
    Jee HB; Park MJ; Lee HS; Park MS; Kim MJ; Chung YE
    PLoS One; 2015; 10(7):e0134133. PubMed ID: 26218533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of non-contrast abdominopelvic computed tomography scans in follow-up of breast cancer patients.
    Nam SY; Ahn SJ; Jang YR; Chun YS; Park HK; Choi SJ; Choi HY; Kim JH
    Br J Radiol; 2021 Feb; 94(1118):20201087. PubMed ID: 33306919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer with synchronous and metachronous hepatic metastasis predicted by enhancement pattern on multiphasic contrast-enhanced CT.
    Tsurumaru D; Nishimuta Y; Muraki T; Asayama Y; Nishie A; Oki E; Honda H
    Eur J Radiol; 2018 Nov; 108():165-171. PubMed ID: 30396650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of liver magnetic resonance imaging after standard staging abdominopelvic computed tomography to evaluate newly diagnosed colorectal cancer patients.
    Han K; Park SH; Kim KW; Kim HJ; Lee SS; Kim JC; Yu CS; Lim SB; Joo YS; Kim AY; Ha HK
    Ann Surg; 2015 Mar; 261(3):480-6. PubMed ID: 24866542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative accuracy of intravenous contrast-enhanced CT versus noncontrast CT plus intravenous contrast-enhanced CT in the detection and characterization of patients with hypervascular liver metastases: a critically appraised topic.
    Sadigh G; Applegate KE; Baumgarten DA
    Acad Radiol; 2014 Jan; 21(1):113-25. PubMed ID: 24331274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria.
    Chung WS; Park MS; Shin SJ; Baek SE; Kim YE; Choi JY; Kim MJ
    AJR Am J Roentgenol; 2012 Oct; 199(4):809-15. PubMed ID: 22997372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of computed tomography virtual noncontrast spectral imaging in evaluation of hepatic metastases: a preliminary study.
    Tian SF; Liu AL; Liu JH; Sun MY; Wang HQ; Liu YJ
    Chin Med J (Engl); 2015 Mar; 128(5):610-4. PubMed ID: 25698191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: initial results from comparison to US seeing separate CT images and to multidetector-row CT alone.
    Stang A; Keles H; Hentschke S; Seydewitz C; Keuchel M; Pohland C; Dahlke J; Weilert H; Wessling J; Malzfeldt E
    Invest Radiol; 2010 Aug; 45(8):491-501. PubMed ID: 20458251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards.
    Wicherts DA; de Haas RJ; van Kessel CS; Bisschops RH; Takahara T; van Hillegersberg R; Bipat S; Rinkes IH; van Leeuwen MS
    Eur J Radiol; 2011 Feb; 77(2):305-11. PubMed ID: 19695807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small (Kim KW; Kim AY; Kim TK; Park SH; Kim HJ; Lee YK; Park MS; Ha HK; Kim PN; Kim JC; Lee MG
    AJR Am J Roentgenol; 2004 May; 182(5):1233-40. PubMed ID: 15100125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
    Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
    Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
    Han NY; Park BJ; Yang KS; Kim MJ; Sung DJ; Sim KC; Cho SB
    AJR Am J Roentgenol; 2017 Nov; 209(5):1039-1045. PubMed ID: 28813196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
    Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MR imaging of hepatic metastasis in patients with malignant melanoma: evaluation of suspected lesions screened at contrast-enhanced CT.
    Sofue K; Tateishi U; Tsurusaki M; Arai Y; Yamazaki N; Sugimura K
    Eur J Radiol; 2012 Apr; 81(4):714-8. PubMed ID: 21353412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy.
    Arita J; Ono Y; Takahashi M; Inoue Y; Takahashi Y; Saiura A
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S390-7. PubMed ID: 24570378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal-phase contrast-enhanced helical CT for the detection of malignant hepatic tumors: sensitivity based on comparison with intraoperative and pathologic findings.
    Kuszyk BS; Bluemke DA; Urban BA; Choti MA; Hruban RH; Sitzmann JV; Fishman EK
    AJR Am J Roentgenol; 1996 Jan; 166(1):91-5. PubMed ID: 8571914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indeterminate solid hepatic lesions identified on non-diagnostic contrast-enhanced computed tomography: assessment of the additional diagnostic value of contrast-enhanced ultrasound in the non-cirrhotic liver.
    Quaia E; De Paoli L; Angileri R; Cabibbo B; Cova MA
    Eur J Radiol; 2014 Mar; 83(3):456-62. PubMed ID: 24387826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.